Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02680184
Title Clinical Study of CMP-001 in Combination With Pembrolizumab
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Checkmate Pharmaceuticals
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Phoenix Arizona 85006 United States Details
University of Arizona Tucson Arizona 85721 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of California, Los Angeles Los Angeles California 90095 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Georgetown Washington District of Columbia 02007 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
University of Pittsburgh Pittsburgh Pennsylvania 15213 United States Details
West Virginia University Morgantown West Virginia 26506 United States Details
*Shaded cells indicate that there was no data available from for the field